DANA MILLER: Open Payments
NPI 1073943064 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,806 in 68 payments from 17 companies in 2025. Trend: 2023 $1,835 · 2024 $2,794 · 2025 $1,806
Food & beverage: $1,806
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 12 | $450 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $284 |
| AstraZeneca Pharmaceuticals LP | 11 | $230 |
| PFIZER INC. | 7 | $154 |
| Merck Sharp & Dohme LLC | 8 | $141 |
| Novartis Pharmaceuticals Corporation | 6 | $127 |
| Novo Nordisk Inc | 4 | $88 |
| Abbott Laboratories | 3 | $73 |
| E.R. Squibb & Sons, L.L.C. | 3 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
Products named: LifeVest, AMVUTTRA, ONPATTRO, VYNDAQEL, LEQVIO, VERQUVO, Wegovy, CARDIOMEMS.
Industry payments across KS — which companies pay providers there.
